Annual Non Current Assets
$51.42 B
+$3.76 B+7.89%
31 December 2023
Summary:
GSK annual long term assets is currently $51.42 billion, with the most recent change of +$3.76 billion (+7.89%) on 31 December 2023. During the last 3 years, it has fallen by -$30.60 billion (-37.31%). GSK annual non current assets is now -37.31% below its all-time high of $82.02 billion, reached on 31 December 2020.GSK Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$54.53 B
+$2.29 B+4.39%
30 September 2024
Summary:
GSK quarterly long term assets is currently $54.53 billion, with the most recent change of +$2.29 billion (+4.39%) on 30 September 2024. Over the past year, it has increased by +$6.19 billion (+12.81%). GSK quarterly non current assets is now -33.72% below its all-time high of $82.27 billion, reached on 30 June 2021.GSK Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.9% | +12.8% |
3 y3 years | -37.3% | -32.8% |
5 y5 years | -1.5% | -28.7% |
GSK Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -37.3% | +7.9% | -33.1% | +29.0% |
5 y | 5 years | -37.3% | +7.9% | -33.7% | +29.0% |
alltime | all time | -37.3% | +5672.1% | -33.7% | +6022.1% |
GSK Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $54.53 B(+4.4%) |
June 2024 | - | $52.24 B(+0.2%) |
Mar 2024 | - | $52.15 B(+1.4%) |
Dec 2023 | $23.75 B(-5.5%) | $51.42 B(+6.4%) |
Sept 2023 | - | $48.34 B(-4.5%) |
June 2023 | - | $50.59 B(+5.1%) |
Mar 2023 | - | $48.15 B(+1.0%) |
Dec 2022 | $25.13 B(-0.3%) | $47.65 B(+6.5%) |
Sept 2022 | - | $44.74 B(+5.8%) |
June 2022 | - | $42.28 B(-47.0%) |
Mar 2022 | - | $79.74 B(-2.2%) |
Dec 2021 | $25.20 B(-8.7%) | $81.56 B(+0.5%) |
Sept 2021 | - | $81.15 B(-1.4%) |
June 2021 | - | $82.27 B(+0.5%) |
Mar 2021 | - | $81.86 B(-0.2%) |
Dec 2020 | $27.59 B(+8.0%) | $82.02 B(+4.4%) |
Sept 2020 | - | $78.53 B(+3.5%) |
June 2020 | - | $75.90 B(-1.6%) |
Mar 2020 | - | $77.14 B(-2.3%) |
Dec 2019 | $25.56 B(+19.0%) | $78.93 B(+3.1%) |
Sept 2019 | - | $76.52 B(+33.0%) |
June 2019 | - | $57.54 B(-1.6%) |
Mar 2019 | - | $58.49 B(+12.0%) |
Dec 2018 | $21.48 B(-0.1%) | $52.20 B(-2.7%) |
Sept 2018 | - | $53.66 B(+1.1%) |
June 2018 | - | $53.07 B(-4.7%) |
Mar 2018 | - | $55.69 B(+1.8%) |
Dec 2017 | $21.50 B(+4.7%) | $54.70 B(-1.0%) |
Sept 2017 | - | $55.23 B(+1.5%) |
June 2017 | - | $54.39 B(+2.7%) |
Mar 2017 | - | $52.96 B(+1.7%) |
Dec 2016 | $20.53 B(-16.5%) | $52.05 B(-2.5%) |
Sept 2016 | - | $53.38 B(-2.7%) |
June 2016 | - | $54.85 B(-1.2%) |
Mar 2016 | - | $55.54 B(+1.7%) |
Dec 2015 | $24.57 B(+7.6%) | $54.61 B(-0.3%) |
Sept 2015 | - | $54.77 B(-3.3%) |
June 2015 | - | $56.61 B(+3.0%) |
Mar 2015 | - | $54.99 B(+36.0%) |
Dec 2014 | $22.85 B(-9.0%) | $40.43 B(-2.2%) |
Sept 2014 | - | $41.32 B(-4.1%) |
June 2014 | - | $43.09 B(-2.2%) |
Mar 2014 | - | $44.05 B(-0.6%) |
Dec 2013 | $25.11 B(+13.5%) | $44.29 B(-0.9%) |
Sept 2013 | - | $44.68 B(+2.3%) |
June 2013 | - | $43.66 B(-0.1%) |
Mar 2013 | - | $43.73 B(-2.6%) |
Dec 2012 | $22.13 B(-11.2%) | $44.91 B(+2.6%) |
Sept 2012 | - | $43.75 B(+11.9%) |
June 2012 | - | $39.09 B(-0.1%) |
Mar 2012 | - | $39.13 B(+1.9%) |
Dec 2011 | $24.91 B(+0.6%) | $38.39 B(-1.6%) |
Sept 2011 | - | $39.01 B(-5.8%) |
June 2011 | - | $41.42 B(-0.0%) |
Mar 2011 | - | $41.42 B(+2.5%) |
Dec 2010 | $24.75 B | $40.43 B(-1.0%) |
Sept 2010 | - | $40.83 B(+5.2%) |
June 2010 | - | $38.81 B(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $39.77 B(-2.8%) |
Dec 2009 | $28.41 B(+12.3%) | $40.90 B(+6.0%) |
Sept 2009 | - | $38.57 B(+13.1%) |
June 2009 | - | $34.10 B(+7.1%) |
Mar 2009 | - | $31.85 B(-1.7%) |
Dec 2008 | $25.29 B(-6.6%) | $32.41 B(-3.8%) |
Sept 2008 | - | $33.68 B(-5.3%) |
June 2008 | - | $35.56 B(+0.6%) |
Mar 2008 | - | $35.36 B(+2.3%) |
Dec 2007 | $27.09 B(+25.9%) | $34.55 B(+3.7%) |
Sept 2007 | - | $33.30 B(+4.6%) |
June 2007 | - | $31.84 B(+4.3%) |
Mar 2007 | - | $30.54 B(+7.1%) |
Dec 2006 | $21.52 B(-5.0%) | $28.51 B(+9.1%) |
Sept 2006 | - | $26.13 B(+2.2%) |
June 2006 | - | $25.57 B(+4.9%) |
Mar 2006 | - | $24.38 B(+1.1%) |
Dec 2005 | $22.66 B(+11.2%) | $24.11 B(+8.6%) |
Sept 2005 | - | $22.20 B(+0.6%) |
June 2005 | - | $22.05 B(-0.4%) |
Mar 2005 | - | $22.15 B(-4.0%) |
Dec 2004 | $20.38 B(-9.6%) | $23.07 B(+5.9%) |
Sept 2004 | - | $21.79 B(+5.1%) |
June 2004 | - | $20.73 B(+1.6%) |
Mar 2004 | - | $20.40 B(+0.6%) |
Dec 2003 | $22.55 B(+30.1%) | $20.27 B(+40.2%) |
Sept 2003 | - | $14.46 B(-24.0%) |
June 2003 | - | $19.03 B(+3.3%) |
Mar 2003 | - | $18.42 B(-1.3%) |
Dec 2002 | $17.33 B(+19.4%) | $18.67 B(+3.6%) |
Sept 2002 | - | $18.02 B(+0.3%) |
June 2002 | - | $17.96 B(+6.1%) |
Mar 2002 | - | $16.93 B(-2.2%) |
Dec 2001 | $14.51 B(-13.6%) | $17.30 B(+2.2%) |
Sept 2001 | - | $16.93 B(+7.4%) |
June 2001 | - | $15.76 B(-2.5%) |
Mar 2001 | - | $16.17 B(+5.1%) |
Dec 2000 | $16.80 B(+71.0%) | $15.39 B(+2.6%) |
Sept 2000 | - | $15.00 B(-2.7%) |
June 2000 | - | $15.41 B(-4.6%) |
Mar 2000 | - | $16.15 B(+130.0%) |
Dec 1999 | $9.82 B(+7.8%) | $7.02 B(+12.5%) |
June 1999 | - | $6.24 B(-1.6%) |
Dec 1998 | $9.11 B(+14.6%) | $6.35 B(+1.3%) |
June 1998 | - | $6.26 B(+4.1%) |
Dec 1997 | $7.95 B(+7.1%) | $6.02 B(-10.2%) |
Dec 1996 | $7.42 B(+11.8%) | $6.71 B(-3.7%) |
Dec 1995 | $6.64 B(+11.4%) | - |
June 1995 | - | $6.96 B(+39.6%) |
June 1995 | $5.96 B(-16.8%) | - |
June 1994 | $7.16 B(+6.9%) | $4.99 B(+9.5%) |
June 1993 | $6.70 B(+6.5%) | $4.56 B(+1.1%) |
June 1992 | $6.29 B(+6.6%) | $4.51 B(+31.8%) |
June 1991 | $5.90 B(+18.1%) | $3.42 B(+20.6%) |
June 1990 | $4.99 B(+41.1%) | $2.84 B(+54.2%) |
June 1989 | $3.54 B(+4.3%) | $1.84 B(+22.1%) |
June 1988 | $3.39 B(+27.2%) | $1.51 B(+33.6%) |
June 1987 | $2.67 B(+42.7%) | $1.13 B(+26.7%) |
June 1986 | $1.87 B | $890.76 M |
FAQ
- What is GSK annual long term assets?
- What is the all time high annual non current assets for GSK?
- What is GSK annual non current assets year-on-year change?
- What is GSK quarterly long term assets?
- What is the all time high quarterly non current assets for GSK?
- What is GSK quarterly non current assets year-on-year change?
What is GSK annual long term assets?
The current annual non current assets of GSK is $51.42 B
What is the all time high annual non current assets for GSK?
GSK all-time high annual long term assets is $82.02 B
What is GSK annual non current assets year-on-year change?
Over the past year, GSK annual long term assets has changed by +$3.76 B (+7.89%)
What is GSK quarterly long term assets?
The current quarterly non current assets of GSK is $54.53 B
What is the all time high quarterly non current assets for GSK?
GSK all-time high quarterly long term assets is $82.27 B
What is GSK quarterly non current assets year-on-year change?
Over the past year, GSK quarterly long term assets has changed by +$6.19 B (+12.81%)